| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Monoclonal T-cell receptors: new reagents for cancer therapy. | Mol Ther | 2007 | 1.34 |
| 2 | Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation. | Nat Biotechnol | 2004 | 1.26 |
| 3 | Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice. | Haematologica | 2009 | 1.00 |
| 4 | Human MHC Class I-restricted high avidity CD4(+) T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivo. | Oncoimmunology | 2013 | 0.88 |
| 5 | WT1-specific T cell receptor gene therapy: improving TCR function in transduced T cells. | Blood Cells Mol Dis | 2007 | 0.85 |
| 6 | T-cell receptor gene therapy for cancer: the progress to date and future objectives. | Expert Opin Biol Ther | 2007 | 0.82 |
| 7 | IL15 can reverse the unresponsiveness of Wilms' tumor antigen-specific CTL in patients with prostate cancer. | Clin Cancer Res | 2009 | 0.81 |